Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Safety was equally impressive. ENV-294 was well tolerated
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
He brings extensive cross-functional expertise built through leadership roles
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
Subscribe To Our Newsletter & Stay Updated
